Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-022947
Filing Date
2020-11-06
Accepted
2020-11-06 12:48:14
Documents
79
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cenb20200930_10q.htm 10-Q 777366
2 EXHIBIT 31.1 ex_210556.htm EX-31.1 11791
3 EXHIBIT 31.2 ex_210557.htm EX-31.2 11918
4 EXHIBIT 32.1 ex_210558.htm EX-32.1 4014
5 EXHIBIT 32.2 ex_210559.htm EX-32.2 4071
  Complete submission text file 0001437749-20-022947.txt   5023217

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cenb-20200930.xml EX-101.INS 971934
7 XBRL TAXONOMY EXTENSION SCHEMA cenb-20200930.xsd EX-101.SCH 70181
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cenb-20200930_cal.xml EX-101.CAL 37947
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cenb-20200930_def.xml EX-101.DEF 426788
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cenb-20200930_lab.xml EX-101.LAB 330641
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cenb-20200930_pre.xml EX-101.PRE 454708
Mailing Address 300-3295 QUALITY WAY WINDSOR A6 N8T 3R9
Business Address 300-3295 QUALITY WAY WINDSOR A6 N8T 3R9 226-344-0660
CEN BIOTECH INC (Filer) CIK: 0001653821 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55557 | Film No.: 201293413
SIC: 2834 Pharmaceutical Preparations